Dieter Kadereit

895 total citations
18 papers, 746 citations indexed

About

Dieter Kadereit is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Dieter Kadereit has authored 18 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Organic Chemistry and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Dieter Kadereit's work include Chemical Synthesis and Analysis (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Receptor Mechanisms and Signaling (3 papers). Dieter Kadereit is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Receptor Mechanisms and Signaling (3 papers). Dieter Kadereit collaborates with scholars based in Germany, France and United States. Dieter Kadereit's co-authors include Herbert Waldmann, Carsten Bolm, Paul A. Wender, Alaric J. Dyckman, Craig O. Husfeld, Heiko Rieck, Jennifer A. Love, Jürgen Kuhlmann, Klaus Arnold and Karsten Kuhn and has published in prestigious journals such as Chemical Reviews, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Dieter Kadereit

17 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dieter Kadereit Germany 14 456 289 117 58 57 18 746
Claudia Piutti Italy 9 337 0.7× 476 1.6× 73 0.6× 33 0.6× 36 0.6× 12 867
Elena Carceller Spain 18 283 0.6× 374 1.3× 62 0.5× 42 0.7× 37 0.6× 42 828
Lihu Yang United States 19 501 1.1× 449 1.6× 174 1.5× 42 0.7× 27 0.5× 39 1.1k
Yun‐Sheng Huang China 16 546 1.2× 192 0.7× 109 0.9× 108 1.9× 60 1.1× 55 965
Minu Dutia United States 14 429 0.9× 336 1.2× 44 0.4× 33 0.6× 14 0.2× 21 908
Diane A. Trainor United States 17 529 1.2× 252 0.9× 44 0.4× 32 0.6× 52 0.9× 22 1.0k
Laurent Knerr Sweden 20 741 1.6× 503 1.7× 25 0.2× 57 1.0× 23 0.4× 41 1.1k
T. MIYASAKA Japan 13 547 1.2× 215 0.7× 115 1.0× 23 0.4× 23 0.4× 37 861
Marlys Hammond United States 15 384 0.8× 426 1.5× 37 0.3× 29 0.5× 19 0.3× 24 778
Markus Boehringer Switzerland 10 588 1.3× 209 0.7× 147 1.3× 15 0.3× 31 0.5× 11 898

Countries citing papers authored by Dieter Kadereit

Since Specialization
Citations

This map shows the geographic impact of Dieter Kadereit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dieter Kadereit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dieter Kadereit more than expected).

Fields of papers citing papers by Dieter Kadereit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dieter Kadereit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dieter Kadereit. The network helps show where Dieter Kadereit may publish in the future.

Co-authorship network of co-authors of Dieter Kadereit

This figure shows the co-authorship network connecting the top 25 collaborators of Dieter Kadereit. A scholar is included among the top collaborators of Dieter Kadereit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dieter Kadereit. Dieter Kadereit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Poirier, Bruno, Dieter Kadereit, Mathias Schäfer, et al.. (2020). A G protein–biased S1P 1 agonist, SAR247799, protects endothelial cells without affecting lymphocyte numbers. Science Signaling. 13(634). 28 indexed citations
2.
Evers, Andreas, Martin Bossart, Stefania Pfeiffer‐Marek, et al.. (2018). Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations. Journal of Medicinal Chemistry. 61(13). 5580–5593. 40 indexed citations
3.
Evers, Andreas, Torsten Haack, M. Lorenz, et al.. (2017). Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists. Journal of Medicinal Chemistry. 60(10). 4293–4303. 89 indexed citations
4.
Kannt, Aimo, et al.. (2012). Selective inhibitors of cardiac ADPR cyclase as novel anti-arrhythmic compounds. Naunyn-Schmiedeberg s Archives of Pharmacology. 385(7). 717–727. 19 indexed citations
5.
Löhn, Matthias, Oliver Plettenburg, Yuri Ivashchenko, et al.. (2009). Pharmacological Characterization of SAR407899, a Novel Rho-Kinase Inhibitor. Hypertension. 54(3). 676–683. 77 indexed citations
6.
Klabunde, Thomas, K. Ulrich Wendt, Dieter Kadereit, et al.. (2005). Acyl Ureas as Human Liver Glycogen Phosphorylase Inhibitors for the Treatment of Type 2 Diabetes. Journal of Medicinal Chemistry. 48(20). 6178–6193. 60 indexed citations
7.
Kadereit, Dieter, Reinhard Reents, Duraiswamy A. Jeyaraj, & Herbert Waldmann. (2003). Introduction and Removal of Protecting Groups. ChemInform. 34(24).
8.
Kadereit, Dieter, et al.. (2001). Acid-Labile Protecting Groups for the Synthesis of Lipidated Peptides. Chemistry - A European Journal. 7(6). 1184–1193. 24 indexed citations
9.
Huster, Daniel, Karsten Kuhn, Dieter Kadereit, Herbert Waldmann, & Klaus Arnold. (2001). 1H High-Resolution Magic Angle Spinning NMR Spectroscopy for the Investigation of a Ras Lipopeptide in a Lipid Membrane. Angewandte Chemie International Edition. 40(6). 1056–1058. 46 indexed citations
10.
Kadereit, Dieter & Herbert Waldmann. (2001). Enzymatic Protecting Group Techniques. Chemical Reviews. 101(11). 3367–3396. 110 indexed citations
11.
Huster, Daniel, Karsten Kuhn, Dieter Kadereit, Herbert Waldmann, & Klaus Arnold. (2001). 1H-HR-MAS-NMR-Spektroskopie zur Untersuchung eines Ras-Lipopeptides in Lipidmembranen. Angewandte Chemie. 113(6). 1083–1085. 7 indexed citations
12.
Kadereit, Dieter, Jürgen Kuhlmann, & Herbert Waldmann. (2000). Linking the Fields—The Interplay of Organic Synthesis, Biophysical Chemistry, and Cell Biology in the Chemical Biology of Protein Lipidation. ChemBioChem. 1(3). 144–169. 35 indexed citations
13.
Kadereit, Dieter & Herbert Waldmann. (2000). Synthesis of Characteristic H-Ras Lipopeptides by Employing Noble-Metal-, Acid-, and Reduction-Labile Blocking Groups. ChemBioChem. 1(3). 200–203. 13 indexed citations
14.
Kadereit, Dieter & Herbert Waldmann. (2000). Synthesis of Characteristic H-Ras Lipopeptides by Employing Noble-Metal-, Acid-, and Reduction-Labile Blocking Groups. ChemBioChem. 1(3). 200–203. 11 indexed citations
15.
Kadereit, Dieter & Herbert Waldmann. (2000). Invited Review Chemoenzymatic Synthesis of Lipidated Peptides. Monatshefte für Chemie - Chemical Monthly. 131(6). 571–584. 8 indexed citations
16.
Rubio, Ignacio, Claudia Meyer, Dieter Kadereit, et al.. (1999). Farnesylation of Ras is important for the interaction with phosphoinositide 3‐kinase γ. European Journal of Biochemistry. 266(1). 70–82. 42 indexed citations
17.
Wender, Paul A., Alaric J. Dyckman, Craig O. Husfeld, et al.. (1999). Transition Metal-Catalyzed [5+2] Cycloadditions with Substituted Cyclopropanes:  First Studies of Regio- and Stereoselectivity. Journal of the American Chemical Society. 121(44). 10442–10443. 80 indexed citations
18.
Bolm, Carsten, et al.. (1997). Enantioselective Olefin Epoxidation with Chiral Manganese/1,4,7-Triazacyclononane Complexes. Synlett. 1997(6). 687–688. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026